跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARIPIPRAZOL LABORATORIOS LICONSA 5 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ARIPIPRAZOL LABORATORIOS LICONSA 5 MG COMPRIMIDOS EFG
Approved
STANDARD
ARIPIPRAZOL LABORATORIOS LICONSA 5 MG COMPRIMIDOS EFG
Laboratorios Liconsa S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 18, 2024
Approval ID
c19996641f2cafe8
Company
Laboratorios Liconsa S.A.
Type
Standard
Approval Details
Approval Id
c19996641f2cafe8
Drug Cima Aemps Name
ARIPIPRAZOL LABORATORIOS LICONSA 5 MG COMPRIMIDOS EFG
Register Number
88891
Holder Company Name
Laboratorios Liconsa S.A.
Marketing Company Name
Laboratorios Liconsa S.A.
Holder Company Detail Path
/organization/laboratorios-liconsa-sa
Marketing Company Detail Path
/organization/laboratorios-liconsa-sa
Authorization Date
2024-01-18
Dosage Form
COMPRIMIDO
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Laboratorios Liconsa S.A.
Company Detail Path
/organization/laboratorios-liconsa-sa
Company Information
Pharmaceutical Company Name
Laboratorios Liconsa SA
Country Name
Spain
Active Ingredients
ARIPIPRAZOL
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 18, 2024
Approval ID
c19996641f2cafe8
Type
Standard
Back to CIMA-AEMPS Approvals
